| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424244100 | Streptococcus (e.g., Group B Streptococcus, pneumococcus or Streptococcus pneumoniae, etc.) | 54 |
| 20080241191 | Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies - Disclosed is a cell wall C-polysaccharide antigen of | 10-02-2008 |
| 20080254070 | Streptococcus pneumoniae proteins and nucleic acid molecules - Protein antigens from | 10-16-2008 |
| 20080292662 | Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae - This invention is about vaccine comprising recombinant CLPP protein of | 11-27-2008 |
| 20090017072 | Vaccine - The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, an immunogenic composition for infants is provided comprising a multivalent | 01-15-2009 |
| 20090136547 | ZWITTERIONIZATION OF CAPSULAR SACCHARIDES - Capsular saccharides are typically anionic. In the invention, however, cationic groups are introduced, such that the modified saccharide has a repeating unit which includes both cationic and anionic groups. These cationic and anionic groups can be balanced to give a zwitterionic repeating unit. These modifications can convert a saccharide that is normally a T-independent antigen into one that can activate T cells without requiring conjugation to a carrier. Typically, the invention modifies an anionic bacterial capsular saccharide antigen by converting a neutral group in the saccharide into a cationic group e.g. to change —NHAc to —NH | 05-28-2009 |
| 20090136548 | MULTIPLE ANTIGENIC PEPTIDES IMMUNOGENIC AGAINST STREPTOCOCCUS PNEUMONIA - The invention provides a nucleic acid encoding the 37-kDa pneumococcal surface adhesion A protein (PsaA) from | 05-28-2009 |
| 20090162401 | Streptococcus Iniae Phosphoglucomutase is a Virulence Factor and Target for Vaccine Development - The present invention relates generally to the identification of virulence factors from | 06-25-2009 |
| 20090214594 | Prevention and Treatment of Otitis Media with Non-Pathogenic Bacterial Strains - This invention relates to a composition comprising a bacterial strain capable of boosting the systemic immune response, a bacterial strain capable of exerting bacteriostatic effects on pathogens associated with development of otitis media such as | 08-27-2009 |
| 20090317427 | Zwitterionic Polysaccharides for Promotion of Immune System Maturation and Health - Certain zwitterionic polysaccharides, including those naturally expressed by commensal | 12-24-2009 |
| 20090324648 | VACCINE FOR EDWARDSIELLA DISEASE AND STREPTOCOCCAL DISEASE IN FISH - Disclosed is a vaccine for edwardsiellosis and streptococcosis in a fish. Specifically, disclosed is a vaccine for edwardsiellosis in a fish, which comprises inactivated cells of (A) an | 12-31-2009 |
| 20100021504 | TREATMENT AND PREVENTION OF ALLERGIC AIRWAYS DISEASES - The present invention provides a method for the treatment or prevention of an allergic airways disease in a subject, the method comprising administering to the subject a composition comprising | 01-28-2010 |
| 20100136057 | Virulence of streptococci - The invention relates to the field of diagnosis of and vaccination against Streptococcal infections and to the detection of virulence markers of Streptococci. The invention discloses a method for modulating virulence of a | 06-03-2010 |
| 20100143414 | PNEUMOCOCCAL SEROTYPES - Disclosed is a new and emerging serotype of | 06-10-2010 |
| 20100143415 | Streptococcus Pneumoniae Antigens - There are provided various novel antigens from | 06-10-2010 |
| 20100158953 | METHOD FOR CONTROLLING STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A POLYSACCHARIDE MOLECULAR WEIGHT - The present invention provides improved methods for producing a solution containing high molecular weight isolated | 06-24-2010 |
| 20100209457 | PNEUMOCOCCAL SEROTYPE 6D - Disclosed is a new and emerging serotype of | 08-19-2010 |
| 20100255034 | Streptococcus Pyogenes Antigens - The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from | 10-07-2010 |
| 20100260802 | RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE - The present invention relates to recombinant lipidated PsaA proteins and recombinant constructs from which such lipidated PsaA proteins may be expressed. The invention relates further to lipidated PsaA proteins in which lipidation is effected by the use of a heterologous leader sequence derived from the ospA gene of | 10-14-2010 |
| 20100272755 | FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM - This invention is in the field of bacterial cultures and specifically relates to the optimization of culture conditions to improve the production of bacterial capsular polysaccharides from | 10-28-2010 |
| 20100297183 | IMMUNOGENIC STREPTOCOCCUS PROTEINS - The invention provides means and methods for identifying a | 11-25-2010 |
| 20100297184 | Vaccines - The invention provides | 11-25-2010 |
| 20100303864 | CONSERVED AND SPECIFIC STREPTOCOCCAL GENOMES - The invention relates to polynucleotides which are conserved or specific to one or more species of | 12-02-2010 |
| 20110002962 | Immunogenic PcpA Polypeptides and Uses Thereof - Provided herein are compositions and methods for eliciting an immune response against | 01-06-2011 |
| 20110020403 | IMMUNIZING COMPOSITION - The present invention is concerned with an antigenic composition comprising at least one antigen that comprises at least one antigenic epitope or antigenic determinant derived from a protein present in one or both of | 01-27-2011 |
| 20110076306 | ARABINOGALACTAN FOR ENHANCING THE ADAPTIVE IMMUNE RESPONSE - The present invention discloses a composition containing Arabinogalactan for enhancing the adaptive immune response in subjects to foreign antigen(s) by administering said composition prior, during and after the phase of exposure to said foreign antigen(s). Furthermore, the present invention relates to a vaccination kit comprising a composition comprising Arabinogalactan and a vaccine. | 03-31-2011 |
| 20110091506 | VACCINE COMPOSITIONS - The present invention provides methods for the treatment or prevention of allergic airways diseases, the suppression of allergic immune responses, and the induction protective immunity against allergic airways diseases wherein the methods comprise administering to subjects in need thereof an effective amount of a | 04-21-2011 |
| 20110110982 | IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE - The invention relates to the identification of a new adhesin islands within the genomes of several Group A and Group B | 05-12-2011 |
| 20110129501 | VACCINE COMPRISING RECOMBINANT CLPP PROTEIN OF STREPTOCOCCUS PNEUMONIAE - A method for immunizing a human or animal against pneumococcal infections, comprising by administering a vaccine comprising a purified recombinant caseinolytic protease P (ClpP) protein of | 06-02-2011 |
| 20110159040 | NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF - An aspect of the present invention provides for methods for identifying novel immunogens that when administered as vaccines elicit a cellular or humoral immunogenic response. In a particular embodiment, a method identified pneumococcal T-cell immunogens that elicit systemic IL-17A responses, and reduce or protect against pneumococcal colonization. | 06-30-2011 |
| 20110171263 | COMPOSITIONS AND METHODS OF USE OF ORF-1358 FROM BETA-HEMOLYTIC STREPTOCOCCAL STRAINS - The present invention relates to polynucleotides encoding | 07-14-2011 |
| 20120021003 | VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS BACTERIA OF VARIOUS SEROTYPES - The present invention pertains to the use of | 01-26-2012 |
| 20120135037 | FLAGELLIN FUSION PROTEINS AND CONJUGATES COMPRISING PNEUMOCOCCUS ANTIGENS AND METHODS OF USING THE SAME - The present invention is based, in part, on flagellin adjuvant used to enhance immune responses directed against | 05-31-2012 |
| 20120164178 | Vaccine - The present invention provides an immunogenic composition comprising a | 06-28-2012 |
| 20120251577 | SELECTIVELY DISRUPTED WHOLE-CELL VACCINE - The present invention provides for immunogenic compositions and methods for producing an immunogenic composition with multiple immunity-inducing fractions of killed, whole-cell | 10-04-2012 |
| 20120258139 | Attenuated Live Vaccines for Aquatic Animals - Safe and effective live vaccines against bacteria infecting aquatic animals were created through the induction of novobiocin-resistance in liquid culture and novobiocin- and rifampicin-resistance in liquid culture. | 10-11-2012 |
| 20120328659 | TREATMENT OF STREPTOCOCCAL INFECTIONS - Immunogenic compositions and methods of treating a | 12-27-2012 |
| 20130004539 | METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASE - The invention provided herein relates to a method of preventing a | 01-03-2013 |
| 20130039947 | NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF - The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection. | 02-14-2013 |
| 20130122047 | STREPTOCOCCUS PYOGENES ANTIGENS - The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from | 05-16-2013 |
| 20130216576 | PNEUMOCOCCAL SEROTYPE 6D - Disclosed is a new and emerging serotype of | 08-22-2013 |
| 20130243818 | Composition Comprising Sortase Anchored Surface Proteins of Streptococcus Uberis - The present invention provides an immunogenic composition comprising one or more | 09-19-2013 |
| 20130315958 | PNEUMOCOCCAL SEROTYPES - Disclosed is a new and emerging serotype of | 11-28-2013 |
| 20140037688 | Materials and Methods for Treating Conditions Associated with Pathogenic Biofilm - The subject invention provides materials and methods that effectively support innate immunity and/or disperse pathogenic biofilms using readily available, nontoxic, natural substances, while supporting restoration of normal microbiotic homeostasis. In one embodiment, the subject invention provides anti-biofilm compositions comprising one or more probiotic organisms, anti-microbial honey, and other ingredients such as prebiotic compounds, other hive products, green tea derivatives, other plant derivatives, and vitamin D3. | 02-06-2014 |
| 20140056944 | ISOLATION OF LYMPHOCYTES AND DELIVERY TO SPLENECTOMY PATIENTS - The present invention includes a method and device for the isolation of lymphocytes, particularly splenic lymphocytes, for administration to patients. In particular for patients undergoing a splenectomy, administration of splenic lymphocytes may increase a patient's immunity and reduce the likelihood of post-splenectomy infections and other complications. | 02-27-2014 |
| 20140186399 | PROTEIN MATRIX VACCINES AND METHODS OF MAKING AND ADMINISTERING SUCH VACCINES - The invention relates to vaccine compositions having a carrier protein and an antigen of interest entrapped in a complex, methods of making such vaccines, and methods of vaccine administration. | 07-03-2014 |
| 20140193461 | STREPTOCOCCUS VACCINE COMPOSITIONS AND METHODS OF USING THE SAME - The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against a bacterial species of the genus | 07-10-2014 |
| 20140205634 | TREATMENT OF STREPTOCOCCAL INFECTIONS - Methods of treating a | 07-24-2014 |
| 20140314812 | LIVE, ATTENUATED STREPTOCOCCUS PNEUMONIAE STRAIN AND VACCINE FOR PROTECTION AGAINST PNEUMOCOCCAL DISEASE - The present invention is an attenuated mutant strain of | 10-23-2014 |
| 20150017209 | Composition for Immunization Against Streptococcus Pneumoniae - This disclosure relates to a method of preventing or treating a recurrence of acute otitis media in a subject at risk comprising administering a therapeutically effective amount of a composition, at least once to the subject. The composition administered comprises at least one immunogenic polypeptide selected from the group consisting of | 01-15-2015 |
| 20150079132 | EVOKING PROTECTION AGAINST STREPTOTOCCUS PNEUMONIAE INCORPORATING B-CELL AND T-CELL PNEUMOCOCCAL PROTEIN ANTIGENS AND PNEUMOCOCCAL POLYSACCHARIDES DELIVERED CONCOMITANTLY - This disclosure is directed to compositions that combine the polysaccharide-specific antibody protection afforded by the conventional vaccines through carrier effects provided by one or more pneumococcal common T-cell antigen(s) together with | 03-19-2015 |
| 20150313986 | PRODUCTION OF HETEROLOGOUS POLYSACCHARIDES IN PLANTS - The invention relates to a novel method for producing bacterial or viral saccharides, such as capsular, immunogenic or membrane saccharides, in a plant cell. Also provided plants, plant cells, plant parts, and plant products comprising such a bacterial or viral saccharide. The invention is based upon the novel finding that bacterial enzymes can be used in a plant cell to produce bacterial or viral capsular, immunogenic and/or membrane saccharides. | 11-05-2015 |
| 20150343051 | IMMUNOGENIC PROTEINS AND COMPOSITIONS - The invention provides proteins and compositions for the treatment and prevention of | 12-03-2015 |
| 20160193318 | VACCINE | 07-07-2016 |
| 20170232101 | Polyvalent Pneumococcal Polysaccharide-Protein Conjugate Composition | 08-17-2017 |
